Literature DB >> 34162927

Worldwide antipsychotic drug search intensities: pharmacoepidemological estimations based on Google Trends data.

Richard Ågren1.   

Abstract

Prescription patterns of antipsychotic drugs (APDs) are typically sourced from country-specific data. In this study, a digital pharmacoepidemiological approach was used to investigate APD preferences globally. Publicly available data on worldwide web search intensities in Google for 19 typical and 22 atypical APDs were temporally and spatially normalized and correlated with reported prescription data. The results demonstrated an increasing global preference for atypical over typical APDs since 2007, with quetiapine, olanzapine, risperidone, and aripiprazole showing the largest search intensities in 2020. Cross-sectional analysis of 122 countries in 2020 showed pronounced differences in atypical/typical APD preferences that correlated with gross domestic product per capita. In conclusion, the investigation provides temporal and spatial assessments of global APD preferences and shows a trend towards atypical APDs, although with a relative preference for typical APDs in low-income countries. Similar data-sourcing methodologies allow for prospective studies of other prescription drugs.

Entities:  

Year:  2021        PMID: 34162927     DOI: 10.1038/s41598-021-92204-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  30 in total

Review 1.  Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia.

Authors:  Bryan L Roth; Douglas J Sheffler; Wesley K Kroeze
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

Review 2.  Cost-effectiveness of atypical antipsychotic medications versus conventional medication.

Authors:  Patricia Hanrahan; Daniel J Luchins; Robert Fabian; George Tolley
Journal:  Expert Opin Pharmacother       Date:  2006-09       Impact factor: 3.889

3.  Cost-effectiveness of first- v. second-generation antipsychotic drugs: results from a randomised controlled trial in schizophrenia responding poorly to previous therapy.

Authors:  L M Davies; S Lewis; P B Jones; T R E Barnes; F Gaughran; K Hayhurst; A Markwick; H Lloyd
Journal:  Br J Psychiatry       Date:  2007-07       Impact factor: 9.319

4.  Antipsychotic treatment and mortality in schizophrenia.

Authors:  Minna Torniainen; Ellenor Mittendorfer-Rutz; Antti Tanskanen; Charlotte Björkenstam; Jaana Suvisaari; Kristina Alexanderson; Jari Tiihonen
Journal:  Schizophr Bull       Date:  2014-11-24       Impact factor: 9.306

Review 5.  Antipsychotic occupancy of dopamine receptors in schizophrenia.

Authors:  Magdalena Nord; Lars Farde
Journal:  CNS Neurosci Ther       Date:  2010-12-08       Impact factor: 5.243

6.  Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia.

Authors:  Robert A Rosenheck; Douglas L Leslie; Jody Sindelar; Edward A Miller; Haiqun Lin; T Scott Stroup; Joseph McEvoy; Sonia M Davis; Richard S E Keefe; Marvin Swartz; Diana O Perkins; John K Hsiao; Jeffrey Lieberman
Journal:  Am J Psychiatry       Date:  2006-12       Impact factor: 18.112

7.  The prevalence and burden of bipolar disorder: findings from the Global Burden of Disease Study 2013.

Authors:  Alize J Ferrari; Emily Stockings; Jon-Paul Khoo; Holly E Erskine; Louisa Degenhardt; Theo Vos; Harvey A Whiteford
Journal:  Bipolar Disord       Date:  2016-08       Impact factor: 6.744

Review 8.  Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016.

Authors:  Fiona J Charlson; Alize J Ferrari; Damian F Santomauro; Sandra Diminic; Emily Stockings; James G Scott; John J McGrath; Harvey A Whiteford
Journal:  Schizophr Bull       Date:  2018-10-17       Impact factor: 9.306

Review 9.  Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles.

Authors:  H A Nasrallah
Journal:  Mol Psychiatry       Date:  2007-09-11       Impact factor: 15.992

10.  Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis.

Authors:  Maximilian Huhn; Adriani Nikolakopoulou; Johannes Schneider-Thoma; Marc Krause; Myrto Samara; Natalie Peter; Thomas Arndt; Lio Bäckers; Philipp Rothe; Andrea Cipriani; John Davis; Georgia Salanti; Stefan Leucht
Journal:  Lancet       Date:  2019-07-11       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.